Alzheimer's Treatment Centers of America
Growth & Strategy Advisor - Healthcare Executive Advisory Board Member
Alzheimer's Treatment Centers of America, New York, New York, United States
About Alzheimer’s Treatment Centers of America (ATCA)
Alzheimer’s Treatment Centers of America uses Artificial Intelligence (AI) + Personalized Precision Medicine to transform the treatment of Alzheimer’s disease, dementia, and brain fog from Long COVID.
This is not about research. This is about treating patients. ATCA goes beyond diagnosing Alzheimer’s and dementia to uncover and address root causes through our innovative treatment protocols.
Our multidisciplinary team, which includes top business executives and medical professionals with expertise in virtual reality and artificial intelligence, is leading the rollout of ATCA Clinics across the U.S.
Why Now?
Immediate Revenue: ATCA is expanding to a multi-clinic organisation incorporating a new prime location...We're Launching Our New Clinic in Palm Beach Gardens, Florida. The Alzheimer's Treatment Centers of America ATCA clinic Palm Beach Gardens/Jupiter is located on the first floor of a two storey building with the Cleveland Clinic as a neighboring tenant. It is located in one of the most affluent areas and has replaced a prior urgent care space which has resulted in high levels of uptake with appointments already booked as far as March.
In-Network with Insurance: ATCA treatments are covered by Medicare, Medicare Advantage, and most major healthcare insurance providers.
Proven Results: In a study using the AI protocol implemented by ATCA, 75% of patients with mild cognitive impairment experienced no further decline.
FDA-Approved Treatment: Includes TB006, which is FDA-approved for compassionate use and has the potential to reverse dementias, including Alzheimer’s.
Physician-Supported: ATCA’s protocols are backed by an experienced Medical Advisory Board of top doctors and scientists. See our Medical Advisory Board:
https://atca.ai/medical-advisory-board/ Key Achievements Proven AI Protocol: Combines cutting-edge AI and precision medicine to deliver highly personalized treatment solutions. Scalable Model: Clinics are designed to deliver a 44% EBITDA margin, supported by strong unit economics. Market Opportunity: The U.S. Alzheimer’s treatment market is valued at $355 billion, with a global opportunity of $1.5 trillion. Research-Driven Care: Clinics also serve as micro-research facilities to advance innovation and generate future revenue streams. Healthcare Growth & Strategy Advisor Job Description ATCA is seeking a senior Healthcare Growth & Strategy Advisor to join its Medical Advisory Board and support the expansion of a next-generation Alzheimer’s treatment platform across the United States. This role is designed for experienced healthcare executives, growth leaders, and physician-operators who have led market expansion, scaling initiatives, or enterprise growth strategies within healthcare organizations. As a Healthcare Growth & Strategy Advisor, you will help guide how ATCA expands nationally while maintaining strong clinical integrity, operational discipline, and sustainable economics. You will work closely with ATCA’s executive leadership, clinical leadership, operations teams, and business development partners to refine growth strategy, prioritize expansion markets, and align clinical innovation with scalable commercial execution. Responsibilities Include Growth Strategy & Market Expansion: Provide strategic guidance on national expansion strategy, market selection, clinic rollout sequencing, and geographic prioritization. Business Development & Partnerships: Advise on building strategic partnerships with health systems, physician groups, referral sources, and enterprise healthcare partners to accelerate growth. Revenue & Unit Economics Optimization: Support refinement of pricing, payer mix strategy, referral economics, and operational levers that drive sustainable, scalable growth. Payer & Network Strategy: Provide insight into Medicare, Medicare Advantage, and commercial payer strategies that support expansion and reimbursement optimization. Precision Medicine Market Positioning: Guide how ATCA’s AI-powered precision medicine model is positioned and differentiated within the broader healthcare and Alzheimer’s treatment landscape. Cross-Functional Growth Alignment: Collaborate with clinical, operational, and technology leaders to ensure growth initiatives align with real-world care delivery and clinical quality. Long-Term Strategic Roadmap: Support development of ATCA’s long-term growth roadmap, including future service lines, partnerships, and platform extensions.
Why Join Us? Transform Patient Outcomes: Help advance a model of Alzheimer’s care that prioritizes early detection, prevention, and coordinated primary care involvement. Influence National Care Delivery: Play a meaningful role in shaping how primary care–informed cognitive care is delivered across a growing network of clinics nationwide. Collaborate with Leaders: Work alongside a world-class team of physicians, scientists, AI experts, and healthcare executives. Be Part of a Defining Moment: Join ATCA at a critical stage of expansion where primary care leadership directly impacts growth, outcomes, and legacy. Compensation / Perks Equity Options: Receive stock options in recognition of your clinical leadership and advisory contributions to ATCA’s mission. Investment Access: Select advisory board members may be offered access to ATCA’s current financing round. Participation is optional and independent of the advisory role. Equal Opportunity Commitment ATCA is committed to fostering an inclusive environment. We believe diversity drives innovation and welcome individuals from all backgrounds to join us in transforming Alzheimer’s treatment.
https://atca.ai/medical-advisory-board/ Key Achievements Proven AI Protocol: Combines cutting-edge AI and precision medicine to deliver highly personalized treatment solutions. Scalable Model: Clinics are designed to deliver a 44% EBITDA margin, supported by strong unit economics. Market Opportunity: The U.S. Alzheimer’s treatment market is valued at $355 billion, with a global opportunity of $1.5 trillion. Research-Driven Care: Clinics also serve as micro-research facilities to advance innovation and generate future revenue streams. Healthcare Growth & Strategy Advisor Job Description ATCA is seeking a senior Healthcare Growth & Strategy Advisor to join its Medical Advisory Board and support the expansion of a next-generation Alzheimer’s treatment platform across the United States. This role is designed for experienced healthcare executives, growth leaders, and physician-operators who have led market expansion, scaling initiatives, or enterprise growth strategies within healthcare organizations. As a Healthcare Growth & Strategy Advisor, you will help guide how ATCA expands nationally while maintaining strong clinical integrity, operational discipline, and sustainable economics. You will work closely with ATCA’s executive leadership, clinical leadership, operations teams, and business development partners to refine growth strategy, prioritize expansion markets, and align clinical innovation with scalable commercial execution. Responsibilities Include Growth Strategy & Market Expansion: Provide strategic guidance on national expansion strategy, market selection, clinic rollout sequencing, and geographic prioritization. Business Development & Partnerships: Advise on building strategic partnerships with health systems, physician groups, referral sources, and enterprise healthcare partners to accelerate growth. Revenue & Unit Economics Optimization: Support refinement of pricing, payer mix strategy, referral economics, and operational levers that drive sustainable, scalable growth. Payer & Network Strategy: Provide insight into Medicare, Medicare Advantage, and commercial payer strategies that support expansion and reimbursement optimization. Precision Medicine Market Positioning: Guide how ATCA’s AI-powered precision medicine model is positioned and differentiated within the broader healthcare and Alzheimer’s treatment landscape. Cross-Functional Growth Alignment: Collaborate with clinical, operational, and technology leaders to ensure growth initiatives align with real-world care delivery and clinical quality. Long-Term Strategic Roadmap: Support development of ATCA’s long-term growth roadmap, including future service lines, partnerships, and platform extensions.
Why Join Us? Transform Patient Outcomes: Help advance a model of Alzheimer’s care that prioritizes early detection, prevention, and coordinated primary care involvement. Influence National Care Delivery: Play a meaningful role in shaping how primary care–informed cognitive care is delivered across a growing network of clinics nationwide. Collaborate with Leaders: Work alongside a world-class team of physicians, scientists, AI experts, and healthcare executives. Be Part of a Defining Moment: Join ATCA at a critical stage of expansion where primary care leadership directly impacts growth, outcomes, and legacy. Compensation / Perks Equity Options: Receive stock options in recognition of your clinical leadership and advisory contributions to ATCA’s mission. Investment Access: Select advisory board members may be offered access to ATCA’s current financing round. Participation is optional and independent of the advisory role. Equal Opportunity Commitment ATCA is committed to fostering an inclusive environment. We believe diversity drives innovation and welcome individuals from all backgrounds to join us in transforming Alzheimer’s treatment.